CM-24 is under clinical development by Purple Biotech and currently in Phase I for Ovarian Cancer. According to GlobalData, Phase I drugs for Ovarian Cancer have a 73% phase transition success rate ...
CM-24 is under clinical development by Purple Biotech and currently in Phase I for Non-Small Cell Lung Cancer.
Mark Spain, 64, who spent decades anchoring the news in Indianapolis, Cleveland, and Jacksonville, died on Dec. 18.
LYNCHBURG, Va. (WSET) — A celebration of life will be held for ABC13's Mark Spain on Saturday, January 4. The service will be ...
11d
Bryony Thomas defied the odds after a devastating pancreatic cancer diagnosis. Five years on, she’s raising awareness and ...
Purple Biotech has identified a new serum biomarker, CEACAM1, which may significantly enhance the efficacy of their oncology therapeutic candidate, CM24, for treating metastatic pancreatic cancer.
With Christmas around the corner, Bryony Thomas was dealt a devastating blow. Her incredible journey through adversity is a ...
in patients with pancreatic ductal adenocarcinoma (PDAC). “We are very excited about the final data, demonstrating CM24’s clear and consistent improvement across all efficacy endpoints evaluated in ...
WSET Lynchburg/Roanoke on MSN18d
Lynchburg community and beyond showed Mark Spain support by wearing purpleRELATED: ABC13's Mark Spain battles Stage 4 pancreatic cancer after diagnosis Last week, our team here at WSET started ...
Hosted on MSN22d
Maine nonprofit stresses importance of early cancer detectionFounded by Stage 4 pancreatic cancer survivor Chris Parrish, Purple Iris Foundation provides a hub for resources and support for those currently battling cancer or for survivors. This includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback